Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Long-term outcome data will ultimately determine these compounds place in obesity treatment
Metformin contributes to weight loss by decreasing glucose production and helping your body use its own insulin more effectively
Zepbound (Tirzepatide Injection) Zepbound is administered weekly through a subcutaneous injection and is clinically proven to activate both GLP-1 and GIP receptors
Under FDA authorization, GLP-1 Agonists Medication is indicated for obese or overweight people, especially those with health conditions like high blood pressure, cardiovascular disease, high cholesterol and other health problems that would benefit from significant weight loss
SPL UNCLASSIFIED SECTION Administration Instruct patients how to prepare and administer the correct dose of ZEPBOUND and assess their ability to inject subcutaneously to ensure the proper administration of ZEPBOUND
US$ 22.66
US$ 21.26
US$ 23.31
US$ 29.45
